COVID-19 Recovery Without B Cells or Antibodies in Patients Receiving Rituximab for Autoimmune Disease

Iran J Kidney Dis. 2021 Mar;1(2):159-160.

Abstract

No Abstract.

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / immunology
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / virology
  • Antibodies, Viral / blood*
  • B-Lymphocytes
  • COVID-19 / diagnosis*
  • COVID-19 / immunology
  • COVID-19 / therapy
  • COVID-19 Serological Testing*
  • Glomerulosclerosis, Focal Segmental / drug therapy
  • Glomerulosclerosis, Focal Segmental / immunology
  • Glomerulosclerosis, Focal Segmental / virology
  • Humans
  • Immunologic Factors / therapeutic use*
  • Retrospective Studies
  • Rituximab / therapeutic use*
  • SARS-CoV-2 / immunology*

Substances

  • Antibodies, Viral
  • Immunologic Factors
  • Rituximab